Aug. 4, 2017

August 04, 2017

The Plant City eatery held its second annual ‘Give Cancer the Boot’ fundraiser Saturday
Plant City Observer – Aug. 4
The Plant City eatery held its second annual “Give Cancer the Boot” event Saturday, to raise money for the Tampa-based Moffitt Center, a leading cancer research and treatment center, and the STANO Foundation. 

Patients Taking Opioids Before ACL Surgery More Likely to Be on Pain Meds Longer
Pain Medicine News – Aug. 4
“This study confirms what we know about postoperative pain management, which is—it does not occur in a vacuum,” said David S. Craig, PharmD, pharmacist lead, supportive care medicine and acute pain, Moffitt Cancer Center in Tampa, Fla. 

New treatment approved for acute myeloid leukemia
Newburgh Gazette – Aug. 3
"Vyxeos is the first chemotherapy to demonstrate an OS advantage over the standard of care in a phase 3 randomized study of older adults with newly-diagnosed therapy-related AML or AML with myelodysplasia-related changes", Jeffrey E. Lancet, MD, chair of the department of malignant hematology at Moffitt Cancer Center, said in the release.
Also seen on Medscape and Healio.

The power of radiomics to improve precision medicine
Science Daily –Aug. 3
In a collaborative project, researchers at the Moffitt Cancer Center and Dana-Farber Cancer Institute investigated the emerging field of radiomics has the potential to improve precision medicine by non-invasively assessing the molecular and clinical characteristics of lung tumors. 

Researchers reveal potential of radiomics to improve precision medicine
News Medical – Aug. 3
"The core belief of radiomics is that images aren't pictures, they're data. We have to treat them as data. Right now, we extract about 1300 different quantitative features from any volume of interest," said Robert Gillies, Ph.D., chair of Moffitt's Department of Cancer Imaging and Metabolism.

American Society for Radiation Oncology members receive fellows designation
Healio – Aug. 3
The 2017 fellows are … Peter Anthony Spencer Johnstone, MD, of Moffitt Cancer Center…

FDA numbers show increase in cancer from breast implants
WNDU – Aug. 3
“The symptoms often come on years after the breast implants are surgically placed,” said Dr. Frederick Locke, a medical oncologist at the Moffitt Cancer Center. Dr. Locke says recent FDA warnings show there have been 359 breast implant-associated lymphoma cases reported. Nine deaths have been documented.

Early Breast Cancer: Radiation Before Surgery Reduce Risk of Second Tumors – Aug. 2
What is the background for this study? What are the main findings? Response: Although radiation therapy after breast-conserving surgery for early-stage breast cancer has significantly improved patient prognosis, many patients will face a second cancer diagnosis within 20 years of primary treatment.

Highlights from Jon Gruden's Bucs Ring of Honor press conference
Tampa Bay Times – Aug. 2
"Well, I love it here. I mean, like I said, my mom and dad have lived down here for a long time. My wife and I are very involved at Moffitt Cancer Center here. The chance to give back to young kids that are playing football, people in the community that need a little help, we're happy to be of assistance any way we can, and proud to be a strong member of the community."

Moffitt Selects Toshiba Interventional Radiology System
24X7 Magazine – Aug. 1
“Time is critical when treating cancer patients, and we acquired the Infinix-i 4D CT to help us provide faster and safer care to more patients,” says Grace Cabral, patient care manager of interventional radiology at Moffitt. Also seen at ITN Online.

Dr. Chavez on Ongoing Efficacy and Challenges With Ibrutinib in CLL
OncLive – Aug. 1
Julio Chavez, MD, of the Department of Malignant Hematology at Moffitt Cancer Center, discusses the ongoing efficacy but also challenges with ibrutinib (Imbruvica) as treatment for patients with chronic lymphocytic leukemia (CLL).

Triple-Negative Breast Cancer Treatment Market Snapshot by 2017 – 2025
MilTech – Aug. 1
According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. 

This Woman's Breast Dimpling Was Her Only Sign of Breast Cancer
Self Magazine – July 31
Dimpling can also be a sign of a rare form of breast cancer known as inflammatory breast cancer. With this form of breast cancer, tumor cells obstruct or block the lymphatic channels that run through the breast and cause the breast skin to look dimpled, similar to the appearance of the skin of an orange, Susan Hoover, M.D., F.A.C.S., a surgical oncologist in the Breast Oncology Program at Moffitt Cancer Center in Tampa, Florida, tells SELF.

Cancer Center Has Long History of Fighting Disparities in Care
Hospitals and Health Networks – July 31
As the only National Cancer Institute-designated Comprehensive Cancer Center in Florida, the Moffitt Cancer Center has placed a premium on health equity for the past 20 years. The cancer center’s leadership recognized that “cancer doesn’t discriminate, so we’ve got to be prepared,” says Cathy Grant, senior director of Moffitt Diversity.

Children Skin Checks
WTVT – July 29
Dr. Jo shares more information about melanoma and Moffitt’s Mole Patrol and pediatric melanoma program.

Mole Patrol
WTVT - July 29
Dr. Vernon Sondak discusses melanoma with Dr. Jo during a live broadcast from Clearwater Beach.

Mole Patrol
WTVT – July 29
Dr. Jane Messina and volunteer Phyllis Hunter discuss Mole Patrol screenings and Melanoma with Dr. Jo during a special event at Clearwater Beach.

Mole Patrol recap
WTVT – July 29
Dr. Jo on Fox 13 recaps the Mole Patrol screening event held at Pier 60 on Clearwater Beach.

Skin Cancer Checks
WTVT – July 28
Moffitt Cancer Center’s Lizette Robles  discusses the Mole Patrol event on Fox 13.

Moffitt To Host Free Skin Cancer Screenings On Clearwater Beach
The Patch – July 28
While people out at Clearwater Beach this weekend may be looking for fun in the sun, the Mole Patrol will be out to help people enjoy the sun safely. Created by Moffitt Cancer Center more than 20 years ago, the Mole Patrol will offer free cancer screenings on Saturday, July 29 from 9 a.m. to 3:30 p.m. at the Pier 60 Pavilion on Clearwater Beach.

New Treatment for Advanced Breast Cancer: Ribociclib
KFSN - July 28
Oncologist Heather Han, MD, of the Moffitt Cancer Center in Tampa, Florida says when combined with hormonal therapy, Ribociclib stops signals that cancer cells use to grow and divide.

Skin cancer cases rising among teens
WTVT – July 28
Dr. Vernon Sondak, Kevin's doctor at the Moffitt Cancer Center, chairs the Cutaneous Oncology Department and has been treating melanoma for decades.  He has noticed a trend.   "No change has been more dramatic in my practice, in career, than the increase in the number of young people – children and adolescents -- that are getting melanoma," he stated.  Rates in teens have been rising two percent per year. 

'Mole Patrol' hits the road for free cancer screenings
WTSP – July 28
Regardless of whether you hold insurance, the skin cancer screening event is free and open to the public. Moffitt Cancer Center is hosting the event.

Mantle Cell Lymphoma: Evaluating the Treatment Landscape
Cancer Therapy Advisor – July 28
Jose D. Sandoval-Sus, MD, of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and colleagues describe an active surveillance schedule for asymptomatic patients with low-risk disease involving complete history, physical exam, complete blood count, complete metabolic panel, and LDH every 3 to 6 months.

Plethora of Novel Agents Transforming Outcomes in Multiple Myeloma
OncLive – July 28
Rachid Baz, MD, associate member, head of the Myeloma Section at Moffitt Cancer Center, gave his presentation “Too Many Cooks in the Kitchen” with regard to the abundance of available therapies for patients with multiple myeloma during the 2017 OncLive® State of the Science Summit™ on Hematologic Malignancies.

Younger Patients With Thin Melanoma May Benefit From Sentinel Node Biopsy
Journal of Clinical Pathways – July 26
Editorialist Dr. Vernon Sondak of Moffitt Cancer Center in Tampa, Florida, told Reuters Health the study is “is important and provocative, but still fairly preliminary - it does not have the statistical power and has not been adequately validated to be considered practice-changing.”


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.